RadioGraphics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1148/rg.273055031
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME Test (opens in a new window)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elaini, A. B.
Right arrow Articles by Blake, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elaini, A. B.
Right arrow Articles by Blake, M. A.
Related Collections
Right arrow Nuclear Medicine
Right arrow Computed Tomography
Right arrow Genitourinary Radiology
RadioGraphics 2007;27:755-767
© RSNA, 2007

EDUCATION EXHIBIT

Improved Detection and Characterization of Adrenal Disease with PET-CT1

A. Bassem Elaini, MD, Sanjay K. Shetty, MD, Vernon M. Chapman, MD, Dushyant V. Sahani, MD, Giles W. Boland, MD, Ann T. Sweeney, MD, Michael M. Maher, MD, James T. Slattery, MRCPI, FFR(RCSI), Peter R. Mueller, MD, and Michael A. Blake, MRCPI, FFR(RCSI), FRCR

1 From the Department of Radiology, Massachusetts General Hospital, FND 216, 55 Fruit St, Boston, MA 02114 (A.B.E., S.K.S., V.M.C., D.V.S., G.W.B., M.M.M., J.T.S., P.R.M., M.A.B.); and the Department of Medicine, Division of Endocrinology, St Elizabeth’s Medical Center, Boston, Mass (A.T.S.). Recipient of a Certificate of Merit award for an education exhibit at the 2004 RSNA Annual Meeting. Received March 1, 2005; revision requested April 4; final revision received June 20, 2006; accepted August 1. All authors have no financial relationships to disclose. Address correspondence to A.B.E. (email: abelaini{at}partners.org).

Positron emission tomography (PET)–computed tomography (CT) combines complementary modalities, thereby providing useful structural and functional information for the detection and characterization of a variety of conditions affecting the adrenal gland. The coregistered information provided by PET-CT is often superior to that provided by CT or PET owing to a variety of pitfalls inherent in the use of either modality alone. In addition, PET-CT can prove invaluable in the differentiation between benign and malignant adrenal disease. However, this combined modality also has certain limitations. Benign entities such as lipid-poor adenomas may demonstrate increased uptake at 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET while being indeterminate at standard CT. Moreover, the combined information from PET-CT will not always obviate additional studies or biopsy. Nevertheless, radiologists and nuclear physicians should be familiar with the common as well as the atypical manifestations of adrenal disease at PET and CT. They should also be meticulous in the performance and interpretation of PET-CT, which is crucial for optimal diagnosis and treatment.

© RSNA, 2007




This article has been cited by other articles:


Home page
 RadiologyHome page
G. W. L. Boland, M. A. Blake, P. F. Hahn, and W. W. Mayo-Smith
Incidental Adrenal Lesions: Principles, Techniques, and Algorithms for Imaging Characterization
Radiology, December 1, 2008; 249(3): 756 - 775.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOGRAPHICS RADIOLOGY RSNA JOURNALS ONLINE
Copyright © 2007 by the Radiological Society of North America.